Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate

NCT06273345 is registered in ClinicalTrials.gov with Istituto Oncologico Veneto IRCCS as lead sponsor.

NCT NCT06273345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06273345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of the Prostate
Lead sponsor
Istituto Oncologico Veneto IRCCS
Phase
Observational
Overall status
Recruiting
Start date
January 23, 2023
Completion date
January 31, 2026
Enrollment
150 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

oligometastatic prostate carcinoma